Back
Novo Nordisk A/S Vs. NovoCure Ltd. Industry Stock Comparison
Sell
33
NVO
Novo Nordisk A/S
Last Price:
$51.16
Seasonality Move:
3.96%
Sell
47
NVCR
NovoCure Ltd.
Last Price:
$13.23
Seasonality Move:
-11.88%
Sell
33
Novo Nordisk A/S (NVO)
is a Sell
Is Novo Nordisk A/S a Buy, Sell or Hold?
-
The current Novo Nordisk A/S [NVO] share price is $51.47. The Score for NVO is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
NovoCure Ltd. (NVCR)
is a Sell
Is NovoCure Ltd. a Buy, Sell or Hold?
-
The current NovoCure Ltd. [NVCR] share price is $13.27. The Score for NVCR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVO Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $51.47The current trend is moderately bullish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
NVCR Stock Price Chart
What is NovoCure Ltd.'s stock price today?
-
The NovoCure Ltd. share price today is $13.27The current trend is moderately bullish and NVCR is experiencing selling pressure, which indicates risk of future bearish movement.
NVO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 57.68 | Buy |
| Chaikin Money Flow: | -10347113 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.88 - 50.6) | Buy |
| Bollinger Bands (100): | (48.47 - 56.99) | Sell |
NVCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 56.21 | Buy |
| Chaikin Money Flow: | -528545 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.98 - 13.34) | Buy |
| Bollinger Bands (100): | (11.66 - 13.54) | Buy |
NVO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 49.95 | Buy |
| 20-day SMA: | 49.04 | Buy |
| 50-day SMA: | 49.45 | Buy |
| 200-day SMA: | 60.18 | Sell |
| 8-day EMA: | 50.65 | Buy |
| 20-day EMA: | 49.64 | Buy |
| 50-day EMA: | 50.41 | Buy |
| 200-day EMA: | 62.52 | Sell |
NVCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.08 | Buy |
| 20-day SMA: | 12.69 | Buy |
| 50-day SMA: | 12.55 | Buy |
| 200-day SMA: | 14.8 | Sell |
| 8-day EMA: | 13.19 | Buy |
| 20-day EMA: | 12.87 | Buy |
| 50-day EMA: | 12.72 | Buy |
| 200-day EMA: | 14.81 | Sell |
Novo Nordisk A/S Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.00 per share.
NovoCure Ltd. Earnings Growth & NVCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.00 per share.
Novo Nordisk A/S Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovoCure Ltd. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||